GO:0019779 Atg8 activating enzyme activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019779 (Atg8 activating enzyme activity) is a molecular_function describing the ATP-dependent activation of the ubiquitin-like protein Atg8/APG8 through formation of a high-energy thiolester bond.
• The reaction is catalyzed by Atg7 (APG7), an E1-like activating enzyme that forms a thiolester with Atg8 before transferring it to the E2-like Atg3.
• Atg8 activation is the first committed step of the Atg8 conjugation cascade that ultimately attaches Atg8 to phosphatidylethanolamine (PE) on autophagosomal membranes.
• Structural plasticity of Atg3 and the E1-E2 interplay determine efficient Atg8-PE conjugation, making this step a regulatory node in autophagy.
• Dysregulation of Atg8 activation and downstream lipidation is linked to Parkinson's disease, lysosomal damage responses, skin autophagy, and fungal autophagy-related immune activation.
• Atg8 activating enzyme activity can be studied with in vitro biochemical reconstitution, structural biology, and CRISPR-based perturbation of ATG7 and related genes.
Description
GO:0019779, Atg8 activating enzyme activity, is a molecular_function term that captures the ATP-dependent activation of the small ubiquitin-related modifier APG8 (Atg8) through formation of a high-energy thiolester bond. This activity is the entry point of the ubiquitin-like conjugation system that decorates autophagosomal membranes with Atg8 family proteins, a hallmark of autophagosome biogenesis and maturation. Because Atg8 lipidation is required for cargo selection, membrane expansion, and autophagosome closure, the enzyme that performs the initial activation step sits at a central control point in macroautophagy. Researchers study Atg8 activating enzyme activity to understand how cells initiate autophagy under stress, how this process is rewired in neurodegeneration and cancer, and how pathogens co-opt or evade autophagy. The reaction is catalyzed by Atg7 (also known as APG7), an E1-like enzyme that uses ATP to form a thiolester with the C-terminal glycine of Atg8 before handing it off to the E2-like Atg3. This cascade is conserved from yeast to humans and is a target of intense structural and biochemical investigation. In this article we define GO:0019779, outline its mechanism, list the key genes and proteins involved, and describe experimental models and CRISPR strategies for dissecting its function in health and disease.
Atg8 activating enzyme activity At A Glance
| GO ID | GO:0019779 |
|---|---|
| GO term | Atg8 activating enzyme activity |
| Ontology | molecular_function |
| Synonym | APG7; APG8 activating enzyme activity |
| Definition | Catalysis of the activation of the small ubiquitin-related modifier APG8, through the formation of an ATP-dependent high-energy thiolester bond |
| Major function | ATP-dependent activation of Atg8/APG8 as the first step of Atg8-PE conjugation in autophagy |
| Representative enzyme | Atg7 (APG7), an E1-like activating enzyme |
| Downstream partner | Atg3 (E2-like) and phosphatidylethanolamine (PE) on autophagosomal membranes |
| Related process | Macroautophagy, selective autophagy, autophagosome biogenesis |
What Is GO:0019779?
Atg8 activating enzyme activity (GO:0019779) is the catalysis of Atg8/APG8 activation via an ATP-dependent high-energy thiolester bond, the first step in the ubiquitin-like conjugation of Atg8 to phosphatidylethanolamine. In practical terms, it is the E1-like enzymatic activity of Atg7 that primes Atg8 for downstream transfer to Atg3 and eventual lipidation on autophagic membranes.
Why Is Atg8 activating enzyme activity Important in Cell Biology?
Atg8 activating enzyme activity is important because it gates the entire Atg8 lipidation cascade that builds functional autophagosomes, and its perturbation alters autophagy flux, cargo recognition, and cellular stress responses. Because autophagy dysfunction is implicated in neurodegeneration, lysosomal storage and damage responses, skin homeostasis, and host-pathogen interactions, the enzymes that execute this activity are high-value targets for mechanistic and therapeutic research.
• It is the first committed step of Atg8-PE conjugation, without which autophagosomes cannot properly form or mature.
• It determines the pool of activated Atg8 available for lipidation on autophagic membranes.
• Its dysregulation is linked to Parkinson's disease and lysosomal damage pathways involving LRRK2 and GABARAP.
• It intersects with neddylation-dependent stabilization of LC3B in skin autophagy.
• It is relevant to SOD1 delivery to lysosomes and maintenance of lysosomal integrity.
• It is conserved in plant autophagy, where phospholipase systems act in the final stages of membrane hydrolysis.
• It is implicated in fungal autophagy and immune activation, with antifungal therapeutic implications.
• It provides a tractable biochemical target for in vitro reconstitution and structural studies.
What Happens During Atg8 activating enzyme activity?
ATP-dependent activation of Atg8
In simple terms: The enzyme uses ATP to 'charge' Atg8 so it can be passed to the next enzyme in the chain.
Atg8 activating enzyme activity begins when Atg7 (APG7) binds ATP and the ubiquitin-like protein Atg8/APG8, forming an ATP-dependent high-energy thiolester bond between the enzyme and the C-terminal glycine of Atg8. This activation step is the defining catalytic event of GO:0019779 and is required before Atg8 can be transferred to the E2-like enzyme Atg3.
Thiolester formation and E1-E2 transfer
In simple terms: The charged Atg8 is handed from the activating enzyme to a carrier enzyme.
Following thiolester formation, Atg8 is transferred from Atg7 to the active-site cysteine of Atg3, an E2-like conjugating enzyme. Structural rearrangements mediated by high-plasticity regions in Atg3 are key for efficient conjugation of Atg8 to PE during autophagy, highlighting that the E1-E2 interface is a regulated and structurally dynamic step.
Atg8-PE conjugation on membranes
In simple terms: The carrier enzyme attaches Atg8 to a lipid in the autophagosome membrane.
Atg3 catalyzes the final conjugation of Atg8 to phosphatidylethanolamine (PE) on autophagosomal membranes, producing Atg8-PE. In vitro biochemical approaches using Atg8-PE have been developed to study this reaction and its regulation, providing a direct readout of the conjugation cascade initiated by Atg8 activating enzyme activity.
Membrane remodeling and autophagosome maturation
In simple terms: Once attached to the membrane, Atg8 helps shape and close the autophagosome.
Atg8-PE supports membrane expansion, cargo recruitment, and autophagosome maturation. In plant autophagy, a dual phospholipase system instructs membrane hydrolysis during the final stages of autophagy, illustrating how Atg8-dependent membrane events are integrated with lipid-remodeling enzymes across kingdoms.
Key Genes Involved in GO:0019779 Atg8 activating enzyme activity
The following genes and proteins are central to Atg8 activating enzyme activity and its downstream conjugation cascade in autophagy.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG7 | E1-like activating enzyme that executes Atg8 activating enzyme activity (GO:0019779) | Core enzyme for Atg8 activation; knockout abolishes Atg8-PE conjugation |
| ATG8 | Ubiquitin-like modifier activated by Atg7 | Substrate of the activating enzyme; readout of autophagy flux |
| MAP1LC3B | Mammalian Atg8 family member (LC3B) | Lipidation reporter; stabilized by neddylation in skin autophagy |
| GABARAP | Mammalian Atg8 family member | Implicated in STING-CASM-GABARAP pathway activating LRRK2 at lysosomes |
| ATG3 | E2-like conjugating enzyme receiving Atg8 from Atg7 | Structural plasticity required for efficient Atg8-PE conjugation |
| ATG4 | Cysteine protease that primes and delipidates Atg8 | Controls availability of Atg8 for activation and recycling |
| ATG5 | Component of the Atg12-Atg5-Atg16L1 complex | Supports Atg8-PE conjugation machinery |
| ATG12 | Ubiquitin-like protein conjugated to Atg5 | Part of the conjugation system that supports Atg8 lipidation |
| ATG16L1 | Scaffold for the Atg12-Atg5 complex | Localizes conjugation machinery to membranes |
| LRRK2 | Kinase linked to lysosomal damage and Parkinson's disease | Activated at lysosomes via STING-CASM-GABARAP pathway |
| STING | Innate immune adaptor | Part of the STING-CASM-GABARAP pathway activating LRRK2 |
| SOD1 | Antioxidant enzyme delivered to lysosomes via autophagy | Maintains lysosomal function and integrity |
| NEDD8 | Ubiquitin-like modifier | Neddylation stabilizes LC3B and promotes autophagy in skin |
| EGCrP2/Sgl1 | Vacuolar sterol beta-glucosidase in Cryptococcus neoformans | Deficiency causes dysfunctional autophagy and immune activation |
| ATG8-PE | Lipidated form of Atg8 on autophagosomes | Biochemical readout of the conjugation cascade |
| Atg3 high-plasticity regions | Structural elements in Atg3 | Key for efficient conjugation of Atg8 to PE |
| Phospholipase system (plant) | Membrane hydrolysis during late autophagy | Links Atg8-dependent membranes to lipid remodeling |
How Is Atg8 activating enzyme activity Regulated?
Atg8 activating enzyme activity is regulated at multiple levels. The E1-E2 interface between Atg7 and Atg3 is structurally dynamic, and high-plasticity regions in Atg3 are required for efficient Atg8-PE conjugation. Upstream signals that control autophagy initiation, such as nutrient status and lysosomal damage responses, influence the availability of Atg8 for activation. Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation, thereby promoting autophagy in skin and indirectly supporting the Atg8 conjugation pathway. In addition, the STING-CASM-GABARAP pathway activates LRRK2 at lysosomes, connecting innate immune signaling to Atg8-family protein function. In fungal systems, loss of the vacuolar sterol beta-glucosidase EGCrP2/Sgl1 causes dysfunctional autophagy, indicating that vacuolar/lysosomal environment influences autophagic flux.
Atg8 activating enzyme activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LRRK2 | Parkinson's disease; lysosomal damage | Knock-in of LRRK2 mutations in neuronal cells; lysosome damage assays |
| MAP1LC3B | Skin autophagy; LC3B stability | Knockout or point mutation of LC3B in keratinocytes; neddylation perturbation |
| SOD1 | Lysosomal function and integrity | SOD1 knockout or tagged knock-in in neuronal cells; autophagy flux assays |
| EGCrP2/Sgl1 | Fungal autophagy; antifungal immunity | Gene deletion in Cryptococcus neoformans; Mincle activation assays |
| ATG7 | Core autophagy; Atg8 activation | ATG7 knockout cells; in vitro reconstitution of Atg8-PE conjugation |
Parkinson's disease and lysosomal damage
LRRK2, lysosome damage, and Parkinson's disease are mechanistically linked, and a STING-CASM-GABARAP pathway activates LRRK2 at lysosomes. Because GABARAP is an Atg8 family protein whose function depends on activation by the Atg8 activating enzyme, perturbations in this cascade may influence LRRK2-driven lysosomal responses relevant to Parkinson's disease.
Skin autophagy and LC3B stability
Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation and promotes autophagy in skin. Since LC3B is a downstream Atg8 family substrate of the activating enzyme, changes in Atg8 activating enzyme activity could modulate skin autophagy and LC3B turnover.
Lysosomal function and SOD1
SOD1 is delivered to lysosomes via autophagy to maintain lysosomal function and integrity. This process depends on functional autophagic machinery, including Atg8 lipidation initiated by Atg8 activating enzyme activity, linking the enzyme to lysosomal homeostasis.
Fungal autophagy and antifungal immunity
In Cryptococcus neoformans, deficiency of the vacuolar sterol beta-glucosidase EGCrP2/Sgl1 causes dysfunctional autophagy and Mincle-dependent immune activation, identifying autophagy-related pathways as targets of novel antifungal strategies. Atg8 activation is a conserved prerequisite for these autophagic functions.
From Atg8 activating enzyme activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Atg8 activating enzyme activity block autophagy? | ATG7 knockout cell lines with LC3B/Atg8 lipidation readouts |
| Which residues are required for thiolester formation? | Point-mutation knock-in of ATG7 catalytic cysteine and Atg8 C-terminal glycine |
| How does Atg3 structural plasticity affect conjugation? | Point mutations in Atg3 high-plasticity regions; in vitro conjugation assays |
| Where does Atg8 activation occur in cells? | Tagged knock-in of ATG7 or Atg8 with fluorescent tags; live imaging |
| Does overexpression of Atg8 family members alter autophagy flux? | Overexpression of LC3B or GABARAP in cell lines; flux assays |
| How does lysosomal damage affect Atg8-dependent pathways? | LRRK2 knock-in or STING pathway perturbation with lysosome damage inducers |
How to Study the Atg8 activating enzyme activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro Atg8-PE conjugation assay | Thiolester formation and lipidation | Mechanistic dissection of Atg8 activating enzyme activity |
| Structural biology (cryo-EM/crystallography) | E1-E2 interfaces and conformational changes | Understanding Atg3 plasticity and catalysis |
| LC3B lipidation immunoblot | Autophagy flux and Atg8 conjugation | Knockout/knock-in validation |
| Fluorescence imaging of tagged Atg8 | Localization of Atg8-PE on membranes | Autophagosome biogenesis studies |
| Lysosome damage assays | Lysosomal integrity and LRRK2 activation | Parkinson's disease models |
| SOD1 trafficking assays | Autophagic delivery to lysosomes | Lysosomal function studies |
| Fungal gene deletion and immune assays | Autophagy dysfunction and Mincle activation | Antifungal target discovery |
| Plant autophagy membrane hydrolysis assays | Late-stage membrane remodeling | Cross-kingdom autophagy comparison |
In vitro reconstitution of Atg8-PE conjugation
Atg8-PE protein-based in vitro biochemical approaches allow direct measurement of the conjugation cascade initiated by Atg8 activating enzyme activity, including thiolester formation and lipidation. These assays use purified Atg7, Atg3, Atg8, and liposomes containing PE to monitor each step.
Structural and biophysical analysis of E1-E2 complexes
Structural rearrangements mediated by high-plasticity regions in Atg3 are key for efficient conjugation of Atg8 to PE, and biophysical methods can resolve how Atg7-Atg8 and Atg3 interfaces change during catalysis. Such studies inform mutagenesis and inhibitor design targeting Atg8 activating enzyme activity.
Autophagy flux and lipidation assays in cells
LC3B lipidation and turnover are standard readouts of autophagy flux, and neddylation-dependent stabilization of LC3B can be monitored to infer changes in the Atg8 conjugation pathway. Combining these assays with ATG7 perturbation provides causal evidence for the role of Atg8 activating enzyme activity.
Disease-relevant pathway interrogation
Pathways such as STING-CASM-GABARAP-LRRK2 at lysosomes and SOD1 delivery to lysosomes can be interrogated with imaging and biochemical fractionation to connect Atg8 activation to disease biology. Fungal models further allow genetic dissection of autophagy-related immune activation.
How CRISPR Can Be Used to Study GO:0019779 Atg8 activating enzyme activity
Knockout
CRISPR knockout of ATG7 abolishes Atg8 activating enzyme activity, providing a clean background to test whether a phenotype depends on Atg8 lipidation. Knockout of downstream genes such as ATG3 or ATG8 family members can further map the pathway.
Point Mutation
Point mutations in the catalytic cysteine of ATG7 or the C-terminal glycine of Atg8 can be introduced to separate activation from downstream conjugation, allowing precise structure-function studies of GO:0019779.
Knock-in
Tagged knock-in of ATG7 or Atg8 family members enables live-cell imaging of the activation and conjugation steps without overexpression artifacts. Knock-in of disease-associated variants such as LRRK2 mutations can link Atg8 activation to lysosomal pathways.
Overexpression
Overexpression of LC3B, GABARAP, or Atg7 can amplify the conjugation cascade for biochemical detection, but must be interpreted with care because it may saturate the pathway. Inducible systems help control expression levels.
How EDITGENE Supports Atg8 activating enzyme activity Research
Researchers studying Atg8 activating enzyme activity-related genes often need to determine whether a candidate gene is causally involved in autophagy initiation, lipidation, or disease-relevant lysosomal pathways. Rigorous causal inference requires well-controlled genetic models that isolate the activation step from downstream conjugation and membrane remodeling.
Contact EDITGENE today to design your custom CRISPR model for Atg8 activating enzyme activity research.
Frequently Asked Questions About Atg8 activating enzyme activity
What is Atg8 activating enzyme activity?
Atg8 activating enzyme activity (GO:0019779) is the ATP-dependent activation of the ubiquitin-like protein Atg8/APG8 through formation of a high-energy thiolester bond, catalyzed by the E1-like enzyme Atg7.
What genes are involved in Atg8 activating enzyme activity?
Key genes include ATG7 (the activating enzyme), ATG8/LC3B/GABARAP (substrates), ATG3 (E2-like), and ATG4, ATG5, ATG12, and ATG16L1 that support the conjugation cascade.
What is the GO ID for Atg8 activating enzyme activity?
The GO ID is GO:0019779, under the molecular_function ontology.
How is Atg8 activated?
Atg7 uses ATP to form a thiolester bond with the C-terminal glycine of Atg8, after which Atg8 is transferred to Atg3 and conjugated to phosphatidylethanolamine on autophagosomal membranes.
Why is Atg8 activating enzyme activity important in autophagy?
It is the first committed step of Atg8-PE conjugation, which is required for autophagosome biogenesis, cargo recruitment, and maturation.
Is Atg8 activating enzyme activity linked to Parkinson's disease?
LRRK2, lysosome damage, and Parkinson's disease are linked, and a STING-CASM-GABARAP pathway activates LRRK2 at lysosomes, connecting Atg8 family proteins to disease-relevant lysosomal responses.
How can I study Atg8 activating enzyme activity in the lab?
In vitro Atg8-PE conjugation assays, structural biology of E1-E2 complexes, LC3B lipidation immunoblots, and CRISPR perturbation of ATG7 are common approaches.
What is the difference between Atg8 activating enzyme activity and Atg8-PE conjugation?
Atg8 activating enzyme activity is the ATP-dependent thiolester formation step, whereas Atg8-PE conjugation is the downstream lipidation reaction on membranes.
Does neddylation affect Atg8 family proteins?
Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation and promotes autophagy in skin, indirectly supporting the Atg8 pathway.
Can CRISPR knockout of ATG7 block autophagy?
Yes, ATG7 knockout abolishes Atg8 activating enzyme activity and provides a clean model to test autophagy-dependent phenotypes.
Conclusion
Atg8 activating enzyme activity (GO:0019779) is the ATP-dependent, thiolester-forming step that initiates Atg8 lipidation and autophagosome biogenesis. Its core enzyme Atg7 and downstream partners Atg3 and Atg8 family proteins are conserved and mechanistically well defined, making this activity a tractable node for autophagy research. Dysregulation of this pathway intersects with Parkinson's disease, lysosomal damage responses, skin autophagy, SOD1 lysosomal delivery, plant autophagy, and fungal immune activation, underscoring its broad biomedical relevance. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with biochemical and imaging assays, provide the tools needed to dissect how Atg8 activating enzyme activity shapes health and disease.
References
- 1. Bentley-DeSousa A et al.. 2025. LRRK2, lysosome damage, and Parkinson's disease.. Curr Opin Cell Biol 93:102482 PMID: 39983584
- 2. Bentley-DeSousa A et al.. 2025. A STING-CASM-GABARAP pathway activates LRRK2 at lysosomes.. J Cell Biol 224(2) PMID: 39812709
- 3. Xu L et al.. 2025. Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation and promoting autophagy in skin.. Proc Natl Acad Sci U S A 122(15):e2411429122 PMID: 40208944
- 4. Zheng Y et al.. 2025. SOD1 is delivered to lysosomes via autophagy to maintain lysosomal function and integrity.. J Cell Biol 224(10) PMID: 40772881
- 5. Huang X et al.. 2022. Atg8-PE protein-based in vitro biochemical approaches to autophagy studies.. Autophagy 18(9):2020-2035 PMID: 35072587
- 6. Popelka H et al.. 2021. Multiple structural rearrangements mediated by high-plasticity regions in Atg3 are key for efficient conjugation of Atg8 to PE during autophagy.. Autophagy 17(8):1805-1808 PMID: 34338142
- 7. Castets J et al.. 2026. A dual phospholipase system instructs membrane hydrolysis during the final stages of plant autophagy.. Nat Commun 17(1) PMID: 42135316
- 8. Watanabe T et al.. 2025. Vacuolar sterol β-glucosidase EGCrP2/Sgl1 deficiency in Cryptococcus neoformans: Dysfunctional autophagy and Mincle-dependent immune activation as targets of novel antifungal strategies.. PLoS Pathog 21(4):e1013089 PMID: 40273119
